Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you take Mounjaro and you're planning a trip abroad, you need to declare it to your travel insurer before you travel. Mounjaro is a prescription-only weight-loss medicine, and most UK travel insurance policies require you to disclose any pre-existing medical condition or ongoing treatment — including prescription medicines — when you buy the policy. Failing to declare it could invalidate a claim. The good news is that travelling on Mounjaro is entirely manageable with a little preparation: getting the medical-history section of your policy right, knowing how to store your pen during transit, and carrying the right documentation are the things that matter most. If you're still exploring whether Mounjaro is right for you, our Mounjaro overview covers the essentials.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is the moment most people hit pause. You're filling in the medical-history section of a travel insurance quote and you're unsure whether a weight-loss prescription counts as something you have to declare. The short answer is: yes, declare it. UK travel insurers broadly define a pre-existing condition as any medical condition for which you are currently receiving treatment or taking medication, and Mounjaro (as a prescription-only medicine) sits squarely in that definition.
What declaration actually means in practice varies by insurer. Some will simply note the medicine and cover you with no change to your premium. Others may ask a few follow-up questions about the underlying condition being treated, whether that is obesity, type 2 diabetes, or a related comorbidity. A small number may apply an exclusion or a loading. The key point is that you find this out before you travel, not at the point of a medical claim abroad. Insurers are entitled to decline claims where a relevant condition or treatment was not disclosed at the point of sale, even if the claim is unrelated to the medicine itself, so the paperwork matters more than it might feel like.
If you are unsure exactly how to phrase the declaration or what category to put Mounjaro in, this guide on adding Mounjaro to travel insurance walks through the process step by step.
Mounjaro comes as a pre-filled KwikPen, and it requires refrigeration between 2°C and 8°C during storage. Checked luggage in an aircraft hold can drop well below freezing, which means you should always carry your active pen in your cabin bag, not in your suitcase. The Patient Information Leaflet sets out the exact permitted room-temperature window for the pen you're currently using, always read the leaflet for your specific strength, because the guidance applies from the moment the pen is first used or removed from the fridge.
Most airlines follow UK Civil Aviation Authority and IATA rules that permit prescription injectable medicines in cabin baggage when accompanied by a prescriber's or pharmacist's letter confirming the medicine, the patient's name, and the requirement to carry needles. When you travel with nume, your consultation is conducted by a GPhC-registered Independent Prescriber, and a letter for travel purposes is something you can request through our aftercare team. Carry needles in their original packaging, and pack a sharps container so you can dispose of used needles safely at your destination.
When your pen arrives from our pharmacy (via DPD the next working day, in plain unbranded packaging, tracked to your door) it comes in labelled, original Eli Lilly packaging. Keep that original box with you when you travel. Customs officers across most countries recognise it; you are far less likely to face delays than if you decant the pen into unmarked containers.
Whether declaring Mounjaro affects the cost or scope of your policy depends almost entirely on the underlying reason you're taking it. If your prescriber is treating obesity alone, many standard policies will note the medicine and cover you normally. If you also have type 2 diabetes, hypertension or another condition, those conditions will each need to be declared in their own right, and it is those that are more likely to affect your premium or trigger exclusions, rather than the Mounjaro itself.
It is worth checking whether your policy covers the cost of replacing medication if your pen is lost, stolen or damaged abroad. Some policies include this as part of personal belongings cover; others exclude prescription medicines explicitly. Read the policy wording carefully rather than assuming. If you're comparing costs or thinking about the overall financial picture of taking Mounjaro, our guide to Mounjaro costs in the UK gives useful context on what private treatment involves.
One question our prescribers hear often is whether stopping Mounjaro briefly before a trip is easier than dealing with storage abroad, and our page on how Mounjaro affects travel insurance covers that and other common concerns in full. This is a clinical decision, not a logistical one, and it is exactly the kind of question to raise at your consultation or aftercare appointment rather than making unilaterally. The NHS patient information on tirzepatide and the NHS England guidance on weight-management injections both provide factual context on ongoing treatment that is worth reading before any conversation with your insurer or prescriber.
Travel with Mounjaro is routine for a growing number of patients, and the friction is almost entirely administrative rather than medical. Before you leave: confirm your travel insurer has a full and accurate declaration on file, and have the policy number and insurer's emergency contact number saved somewhere accessible. Carry your pen in cabin baggage in its original packaging, alongside your prescriber's letter and the Patient Information Leaflet. Check the specific room-temperature guidance in the leaflet for your current pen strength before you depart. If you're travelling across multiple time zones, note that Mounjaro is dosed once weekly rather than daily, which makes timing far simpler than with daily medicines, but any adjustment to timing should be agreed with your prescriber first.
If you're already on treatment and have questions about a specific insurer's approach, our page on Admiral travel insurance and Mounjaro may be useful, and you can find broader guidance on whether you need to declare Mounjaro on travel insurance in our related content. For anything clinical (whether to pause, whether storage arrangements for a particular trip are safe, or how a dose fits around a long journey) our prescribers are available through aftercare seven days a week.
If you haven't yet started treatment and would like a clinical assessment, start your free consultation with a GPhC-registered prescriber at nume today.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.